Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor RECK via down regulation of its target gene, 26/March/2014, 5.01 am

Insights into Cell-density-dependent miRNA Biogenesis: The ubiquitin ligase COP1 suppresses wide spread miRNA processing through degradation of its target gene, 26/March/2014, 4.35 am
March 25, 2014
Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor TIMP3 via down regulation of its target gene, 26/March/2014, 5.04 am
March 25, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Fulvestrant, an estrogen receptor antagonist, increases the expression of tumor suppressor RECK via down regulation of its target gene, 26/March/2014, 5.01 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.